In:
Clinical Case Reports, Wiley, Vol. 10, No. 1 ( 2022-01)
Abstract:
Rhabdomyolysis (RM) is a potentially life‐threatening entity that can lead to acute kidney injury (AKI). Continuous renal replacement therapy (CRRT) alone is known as effective therapy, but the additional use of a hemoadsorber (like CytoSorb ® ) might increase its efficacy.
Type of Medium:
Online Resource
ISSN:
2050-0904
,
2050-0904
Language:
English
Publisher:
Wiley
Publication Date:
2022
detail.hit.zdb_id:
2740234-4